
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 2, 2001]
[Document not affected by Public Laws enacted between
  January 2, 2001 and January 28, 2002]
[CITE: 10USC1110]

 
                         TITLE 10--ARMED FORCES
 
                    Subtitle A--General Military Law
 
                           PART II--PERSONNEL
 
                   CHAPTER 55--MEDICAL AND DENTAL CARE
 
Sec. 1110. Anthrax vaccine immunization program; procedures for 
        exemptions and monitoring reactions
        
    (a) Procedures for Medical and Administrative Exemptions.--(1) The 
Secretary of Defense shall establish uniform procedures under which 
members of the armed forces may be exempted from participating in the 
anthrax vaccine immunization program for either administrative or 
medical reasons.
    (2) The Secretaries of the military departments shall provide for 
notification of all members of the armed forces of the procedures 
established pursuant to paragraph (1).
    (b) System for Monitoring Adverse Reactions.--(1) The Secretary 
shall establish a system for monitoring adverse reactions of members of 
the armed forces to the anthrax vaccine. That system shall include the 
following:
        (A) Independent review of Vaccine Adverse Event Reporting System 
    reports.
        (B) Periodic surveys of personnel to whom the vaccine is 
    administered.
        (C) A continuing longitudinal study of a pre-identified group of 
    members of the armed forces (including men and women and members 
    from all services).
        (D) Active surveillance of a sample of members to whom the 
    anthrax vaccine has been administered that is sufficient to 
    identify, at the earliest opportunity, any patterns of adverse 
    reactions, the discovery of which might be delayed by reliance 
    solely on the Vaccine Adverse Event Reporting System.

    (2) The Secretary may extend or expand any ongoing or planned study 
or analysis of trends in adverse reactions of members of the armed 
forces to the anthrax vaccine in order to meet any of the requirements 
in paragraph (1).
    (3) The Secretary shall establish guidelines under which members of 
the armed forces who are determined by an independent expert panel to be 
experiencing unexplained adverse reactions may obtain access to a 
Department of Defense Center of Excellence treatment facility for 
expedited treatment and follow up.

(Added Pub. L. 106-398, Sec. 1 [[div. A], title VII, Sec. 751(b)(1)], 
Oct. 30, 2000, 114 Stat. 1654, 1654A-193.)


             Deadlines for Establishment and Implementation

    Pub. L. 106-398, Sec. 1 [[div. A], title VII, Sec. 751(e)], Oct. 30, 
2000, 114 Stat. 1654, 1654A-195, provided that: ``The Secretary of 
Defense shall--
        ``(1) not later than April 1, 2001, establish the uniform 
    procedures for exemption from participation in the anthrax vaccine 
    immunization program of the Department of Defense required under 
    subsection (a) of section 1110 of title 10, United States Code (as 
    added by subsection (b));
        ``(2) not later than July 1, 2001, establish the system for 
    monitoring adverse reactions of members of the Armed Forces to the 
    anthrax vaccine required under subsection (b)(1) of such section;
        ``(3) not later than April 1, 2001, establish the guidelines 
    under which members of the Armed Forces may obtain access to a 
    Department of Defense Center of Excellence treatment facility for 
    expedited treatment and follow up required under subsection (b)(3) 
    of such section; and
        ``(4) not later than July 1, 2001, prescribe the regulations 
    regarding emergency essential employees of the Department of Defense 
    required under subsection (a) of section 1580a of such title (as 
    added by subsection(c)).''
